# Birchview Capital, LP: Form 13F holdings

An institutional investment manager in BURLINGTON, VT. SEC CIK 1618205.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $213.8m
- Positions: 72 (73 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1618205/000161820526000003/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [KLA CORPORATION (KLAC)](/companies/klac.md) | COM NEW | $53.8m | 25.2% | 178,471 |  | Added +158,588 |
| [BRISTOL-MYERS SQUIBB CO (BMY)](/companies/bmy.md) | COM | $17.1m | 8.0% | 297,243 |  | Reduced −9,025 |
| [LAM RESEARCH CORPORATION (LRCX)](/companies/lrcx.md) | COM NEW | $15.2m | 7.1% | 35,000 |  | Reduced −1,000 |
| [INTELLIA THERAPEUTICS INC (NTLA)](/companies/ntla.md) | COM | $6.8m | 3.2% | 385,900 |  | Reduced −59,500 |
| [SOLID BIOSCIENCES INC (SLDB)](/companies/sldb.md) | COM NEW | $6.7m | 3.1% | 666,196 |  | Added +40,216 |
| BIODESIX INC | COM | $6.5m | 3.0% | 286,804 |  | Unchanged |
| [STOKE THERAPEUTICS INC (STOK)](/companies/stok.md) | COM | $5.8m | 2.7% | 178,110 |  | Reduced −31,890 |
| [OVINTIV INC (OVV)](/companies/ovv.md) | COM | $5.7m | 2.6% | 107,500 |  | Unchanged |
| [NEKTAR THERAPEUTICS (NKTR)](/companies/nktr.md) | COM | $5.7m | 2.6% | 81,000 |  | Added +50,000 |
| [CORCEPT THERAPEUTICS INC (CORT)](/companies/cort.md) | COM | $5.0m | 2.3% | 57,200 |  | Added +10,000 |
| [NEUROCRINE BIOSCIENCES INC (NBIX)](/companies/nbix.md) | COM | $4.6m | 2.1% | 27,190 |  | Unchanged |
| PROTHENA CORP PLC | SHS | $4.4m | 2.1% | 449,019 |  | Unchanged |
| [ACADIA PHARMACEUTICALS INC (ACAD)](/companies/acad.md) | COM | $4.3m | 2.0% | 171,000 |  | Unchanged |
| [PROTAGONIST THERAPEUTICS INC (PTGX)](/companies/ptgx.md) | COM | $4.3m | 2.0% | 35,018 |  | Added +18 |
| [COMPASS THERAPEUTICS INC (CMPX)](/companies/cmpx.md) | COM | $3.7m | 1.7% | 1,675,000 |  | Added +209,133 |
| [RELMADA THERAPEUTICS INC (RLMD)](/companies/rlmd.md) | COM | $2.8m | 1.3% | 408,100 |  | Reduced −1,287 |
| ALKERMES PLC | SHS | $2.6m | 1.2% | 50,000 |  | Unchanged |
| [HALOZYME THERAPEUTICS INC (HALO)](/companies/halo.md) | COM | $2.6m | 1.2% | 33,251 |  | Added +23,151 |
| [CELLDEX THERAPEUTICS INC (CLDX)](/companies/cldx.md) | COM NEW | $2.6m | 1.2% | 69,900 |  | Reduced −195 |
| [CYTOKINETICS INC (CYTK)](/companies/cytk.md) | COM | $2.6m | 1.2% | 30,000 |  | Unchanged |
| [OLEMA PHARMACEUTICALS INC (OLMA)](/companies/olma.md) | COM | $2.5m | 1.2% | 199,000 |  | Reduced −20,000 |
| [VERA THERAPEUTICS INC (VERA)](/companies/vera.md) | CL A | $2.5m | 1.2% | 57,758 |  | Added +13,758 |
| [UNITED THERAPEUTICS CORP (UTHR)](/companies/uthr.md) | COM | $2.4m | 1.1% | 4,506 |  | Added +6 |
| [ZENAS BIOPHARMA INC (ZBIO)](/companies/zbio.md) | COM | $2.4m | 1.1% | 93,601 |  | Added +23,601 |
| UNIQURE NV | SHS | $2.3m | 1.1% | 50,697 |  | Reduced −50,000 |
| [PACIFIC BIOSCIENCES OF CALIFORNIA INC (PACB)](/companies/pacb.md) | COM | $2.3m | 1.1% | 1,350,000 |  | Reduced −150,000 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $2.3m | 1.1% | 17,000 |  | New +17,000 |
| [VIR BIOTECHNOLOGY INC (VIR)](/companies/vir.md) | COM | $2.2m | 1.0% | 220,000 |  | New +220,000 |
| [BIOGEN INC (BIIB)](/companies/biib.md) | COM | $1.9m | 0.9% | 9,000 |  | Added +4,000 |
| [EQT CORPORATION (EQT)](/companies/eqt.md) | COM | $1.8m | 0.9% | 34,619 |  | Unchanged |
| [BIOAGE LABS INC (BIOA)](/companies/bioa.md) | COM | $1.7m | 0.8% | 69,000 |  | New +69,000 |
| [TRAVERE THERAPEUTICS INC (TVTX)](/companies/tvtx.md) | COM | $1.6m | 0.8% | 29,000 |  | Reduced −200 |
| QUIDELORTHO CORP | COM | $1.6m | 0.7% | 89,377 |  | Added +6,829 |
| [AXSOME THERAPEUTICS INC (AXSM)](/companies/axsm.md) | COM | $1.5m | 0.7% | 6,000 |  | Unchanged |
| [FOGHORN THERAPEUTICS INC (FHTX)](/companies/fhtx.md) | COM | $1.4m | 0.6% | 281,937 |  | Added +207 |
| [BICYCLE THERAPEUTICS PLC (BCYC)](/companies/bcyc.md) | SPONSORED ADS | $1.3m | 0.6% | 313,616 |  | Reduced −149,983 |
| [STRUCTURE THERAPEUTICS INC (GPCR)](/companies/gpcr.md) | SPONS ADR | $1.3m | 0.6% | 24,000 |  | Reduced −76,000 |
| [XENON PHARMACEUTICALS INC (XENE)](/companies/xene.md) | COM | $1.3m | 0.6% | 21,032 |  | Added +32 |
| [NOVO NORDISK A/S (NVO)](/companies/nvo.md) | ADR | $1.2m | 0.5% | 24,000 |  | New +24,000 |
| [FREEPORT-MCMORAN CL-B (FCX)](/companies/fcx.md) | CL-B | $1.1m | 0.5% | 18,035 |  | Reduced −5 |
| [IMMUNOME INC (IMNM)](/companies/imnm.md) | COM | $1.1m | 0.5% | 50,000 |  | Unchanged |
| PHARVARIS N V | COM | $1.0m | 0.5% | 29,847 |  | Unchanged |
| [HARROW HEALTH INC (HROW)](/companies/hrow.md) | COM | $1.0m | 0.5% | 24,000 |  | Unchanged |
| [ADAGENE INC (ADAG)](/companies/adag.md) | ADS | $1.0m | 0.5% | 240,000 |  | New +240,000 |
| [DEFINIUM THERAPEUTICS INC (DFTX)](/companies/dftx.md) | COM SHS | $940.8k | 0.4% | 20,000 |  | New +20,000 |
| [SILENCE THERAPEUTICS PLC (SLN)](/companies/sln.md) | ADS | $782.0k | 0.4% | 71,218 |  | New +71,218 |
| [BRIDGEBIO PHARMA INC (BBIO)](/companies/bbio.md) | COM | $651.0k | 0.3% | 8,741 |  | Added +53 |
| [4D MOLECULAR THERAPEUTICS INC (FDMT)](/companies/fdmt.md) | COM | $645.1k | 0.3% | 48,505 |  | New +48,505 |
| UROGEN PHARMA LTD | COM | $606.7k | 0.3% | 16,487 |  | New +16,487 |
| [PHATHOM PHARMACEUTICALS INC (PHAT)](/companies/phat.md) | COM | $596.8k | 0.3% | 55,000 |  | Reduced −140,000 |
| [CAMP4 THERAPEUTICS CORP (CAMP)](/companies/camp.md) | COM | $524.4k | 0.2% | 120,000 |  | New +120,000 |
| [SAVARA INC (SVRA)](/companies/svra.md) | COM | $492.8k | 0.2% | 80,000 |  | New +80,000 |
| [CANDEL THERAPEUTICS INC (CADL)](/companies/cadl.md) | COM | $491.9k | 0.2% | 47,756 |  | Reduced −12,244 |
| [ALTIMMUNE INC (ALT)](/companies/alt.md) | COM NEW | $464.1k | 0.2% | 152,681 |  | New +152,681 |
| [COMPASS PATHWAYS LTD (CMPS)](/companies/cmps.md) | SPONSORED ADS | $424.5k | 0.2% | 30,000 |  | Reduced −345,000 |
| KARYOPHARM THERAPEUTICS INC | COM | $419.6k | 0.2% | 42,952 |  | Reduced −41,000 |
| [CULLINAN THERAPEUTICS INC (CGEM)](/companies/cgem.md) | COM | $364.2k | 0.2% | 20,000 |  | Unchanged |
| [TRINITY CAP INC (TRIN)](/companies/trin.md) | COM | $357.8k | 0.2% | 20,000 |  | Unchanged |
| [CAPRICOR THERAPEUTICS INC (CAPR)](/companies/capr.md) | COM NEW | $345.6k | 0.2% | 14,352 |  | New +14,352 |
| [CASTLE BIOSCIENCES INC (CSTL)](/companies/cstl.md) | COM | $309.7k | 0.1% | 12,984 |  | Added +84 |
| [INVIVYD INC (IVVD)](/companies/ivvd.md) | COM | $298.6k | 0.1% | 342,275 |  | New +342,275 |
| [GRACE THERAPEUTICS INC (GRCE)](/companies/grce.md) | COM | $272.4k | 0.1% | 120,000 |  | Added +70,000 |
| [KAYNE ANDERSON BDC INC (KBDC)](/companies/kbdc.md) | COM SHS | $270.6k | 0.1% | 20,000 |  | Unchanged |
| [VOYAGER THERAPEUTICS INC (VYGR)](/companies/vygr.md) | COM | $263.0k | 0.1% | 75,147 |  | Added +229 |
| [PULMONX CORP (LUNG)](/companies/lung.md) | COM | $260.7k | 0.1% | 200,543 |  | Reduced −49,678 |
| [OCULAR THERAPEUTIX INC (OCUL)](/companies/ocul.md) | COM | $202.8k | <0.1% | 20,655 |  | Reduced −299,345 |
| [KYNTRA BIO INC (KYNB)](/companies/kynb.md) | COM NEW | $170.4k | <0.1% | 22,566 |  | Unchanged |
| [ELUTIA INC (ELUT)](/companies/elut.md) | COM | $161.7k | <0.1% | 165,094 |  | Unchanged |
| [QUOIN PHARMACEUTICALS LTD (QNRX)](/companies/qnrx.md) | SPONSORED ADS | $96.8k | <0.1% | 20,000 |  | Unchanged |
| [LIPOCINE INC (LPCN)](/companies/lpcn.md) | COM NEW | $42.8k | <0.1% | 16,712 |  | Reduced −95,074 |
| [DOCGO INC (DCGO)](/companies/dcgo.md) | COM | $20.2k | <0.1% | 39,062 |  | Reduced −511 |
| GOSSAMER BIO INC | COM | $3.0k | <0.1% | 18,176 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| APELLIS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −14,000 |
| APOGEE THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −9,000 |
| [ARCUS BIOSCIENCES INC (RCUS)](/companies/rcus.md) | COM | $0 | 0.0% | 0 |  | Sold out −25,889 |
| ENGENE HOLDINGS INC | COM | $0 | 0.0% | 0 |  | Sold out −250,000 |
| [IDEAYA BIOSCIENCES INC (IDYA)](/companies/idya.md) | COM | $0 | 0.0% | 0 |  | Sold out −16,860 |
| KALVISTA PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −57,000 |
| NOVOCURE LTD | ORD SHS | $0 | 0.0% | 0 |  | Sold out −202,330 |
| OUTSET MEDICAL INC | COM | $0 | 0.0% | 0 |  | Sold out −98,882 |
| [PHREESIA INC (PHR)](/companies/phr.md) | COM | $0 | 0.0% | 0 |  | Sold out −14,300 |
| [REGENXBIO INC (RGNX)](/companies/rgnx.md) | COM | $0 | 0.0% | 0 |  | Sold out −66,270 |
| [ROCKET PHARMACEUTICALS INC (RCKT)](/companies/rckt.md) | COM | $0 | 0.0% | 0 |  | Sold out −127,025 |
| [ULTRAGENYX PHARMACEUTICAL INC (RARE)](/companies/rare.md) | COM | $0 | 0.0% | 0 |  | Sold out −62,000 |
| [VERASTEM INC (VSTM)](/companies/vstm.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −150,000 |
| [VIRIDIAN THERAPEUTICS INC (VRDN)](/companies/vrdn.md) | COM | $0 | 0.0% | 0 |  | Sold out −20,100 |
| [ZENTALIS PHARMACEUTICALS INC (ZNTL)](/companies/zntl.md) | COM | $0 | 0.0% | 0 |  | Sold out −17,503 |

Source: SEC EDGAR, Form 13F-HR, accession 0001618205-26-000003. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.